MARKET

CHRO

CHRO

Chromocell Therapeutics Corporation
AMEX
1.770
-0.020
-1.12%
Closed 15:16 05/01 EDT
OPEN
1.805
PREV CLOSE
1.790
HIGH
1.805
LOW
1.760
VOLUME
4.02K
TURNOVER
0
52 WEEK HIGH
6.00
52 WEEK LOW
1.210
MARKET CAP
10.40M
P/E (TTM)
-1.3831
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at CHRO last week (0422-0426)?
Weekly Report · 3d ago
Weekly Report: what happened at CHRO last week (0415-0419)?
Weekly Report · 04/22 12:45
SBFM, BPTH and INDO among pre-market losers
On the Move SBFM, BPTH and INDO among pre-market losers. Hepion Pharmaceuticals -38% initiates wind-down activities in Phase 2b ‘ASCEND-NASH’ trial. Terronera surpasses 50% construction completion.
Seeking Alpha · 04/22 12:23
Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Super Micro Computer, Inc. Shares fell 13.2% to $806.00 on Friday. The company announced its third-quarter earnings date and did not provide preliminary estimates. Next.e.GO shares jumped 129% in the mid-day session. Redwoods Acquisition Corp. Shares rose 62.5% after falling around 3%.
Benzinga · 04/19 17:25
12 Health Care Stocks Moving In Friday's Pre-Market Session
Chromocell Therapeutics (AMEX:CHRO) stock increased by 21.6% to $1.49 during Friday's pre-market session. Kineta stock moved upwards by 16.62% and Erasca stock rose 13.73%. Nexalin Technology (NASDAQ:NXL) stock fell 18.4% during the day.
Benzinga · 04/19 12:08
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
The Travelers Companies, Inc. Shares dipped 8.1% to $205.03 on Wednesday. Travelers reported a mixed first quarter, with earnings lagging analyst' expectations. InVO Bioscience shares shot up 256% after the company reported a year-over-year increase in fourth-quarter revenue.
Benzinga · 04/17 17:36
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
INVO Bioscience shares increased by 93.4% to $1.47 during Wednesday's pre-market session. The company's, Q4 earnings came out yesterday. Clene shares moved upwards by 40.8% and Galera Therapeutics shares moved up by 31.6%. Sage Therapeutic (NASDAQ:SAGE) stock decreased by 19.4%.
Benzinga · 04/17 12:08
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
INVO Bioscience stock is rocketing more than 55% alongside its Q4 earnings report. Vanda Pharmaceuticals shares are soaring over 38% on a firm acquisition proposal. VIA Optronics stock is surging more than 32% with heavy pre-market trading. Moving stocks this morning are earnings reports, acquisition plans, new drug data and more.
Investorplace · 04/17 11:33
More
About CHRO
Chromocell Therapeutics Corporation is a clinical-stage biotech company, which is focused on developing and commercializing therapeutics to alleviate pain. The Company's clinical focus is to selectively target the sodium ion-channel, NaV1.7, as well as other receptors in the NaV family. Its lead compound, CC8464, is designed to address both the underlying condition and mitigate the burning pain symptoms, which erythromelalgia (EM) patients experience by blocking the NaV1.7 sodium channel. CC8464 has completed Phase I study. A total of approximately 207 healthy subjects have been dosed in four Phase I studies (CC8464-1001, CC8464-1002, CC8464-1003, and 1807-CL-0102) with study treatment.

Webull offers Chromocell Therapeutics Corp stock information, including AMEX: CHRO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CHRO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CHRO stock methods without spending real money on the virtual paper trading platform.